Cue Biopharma, Inc.
USD34.03
+3.60 (+11.83%)
CEO
Lucinda Warren
IPO Date
2018-01-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$30.60
Prev. Close
$30.43
Day Low
$30.60
Day High
$35.00
52W Low
$4.98
52W High
$41.42
Market Cap
$0.09B
Volume
0.16M
| -1.5 |
| 31 Dec 2023 | FY | -593.9% | -924.1% | -136.8% | -82.5% | 0.40 | 3.01 | -2.4 |
| 31 Dec 2022 | FY | 100.0% | -4257.8% | -80.7% | -58.1% | 0.29 | 6.68 | -1.9 |
| 31 Dec 2021 | FY | 111.9% | -295.6% | -67.4% | -53.0% | 0.18 | 5.35 | -8.0 |
| 31 Dec 2020 | FY | -963.5% | -1419.8% | -56.8% | -45.0% | 0.09 | 5.36 | -8.0 |
| 31 Dec 2019 | FY | -694.8% | -1061.2% | -67.2% | -51.3% | 0.11 | 5.24 | -9.5 |
| 31 Dec 2018 | FY | -2398.2% | -3411.5% | -114.7% | -85.9% | 0.00 | 6.53 | -2.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -37.7% | -34.7% | 0.04 | 12.17 | -10.3 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -50.5% | -47.0% | 0.00 | 14.18 | -31.3 |
| 5.2 |
| 30 Sept 2025 | Q3 | 96.3% | -346.6% | -56.2% | -23.5% | 0.47 | 1.66 | -2.4 |
| 30 Jun 2025 | Q2 | 100.0% | -287.1% | -46.7% | -20.8% | 0.42 | 1.60 | -1.9 |
| 31 Mar 2025 | Q1 | 100.0% | -2911.4% | -186.3% | -55.1% | 1.08 | 1.03 | -1.4 |
| 31 Dec 2024 | Q4 | 100.0% | -602.5% | -54.3% | -29.5% | 0.51 | 1.84 | -2.1 |
| 30 Sept 2024 | Q3 | 100.0% | -259.6% | -34.1% | -19.3% | 0.37 | 2.22 | -1.1 |
| 30 Jun 2024 | Q2 | 100.0% | -382.7% | -47.0% | -24.0% | 0.52 | 2.06 | -1.3 |
| 31 Mar 2024 | Q1 | 100.0% | -719.1% | -41.1% | -22.9% | 0.43 | 2.47 | -1.9 |
| 31 Dec 2023 | Q4 | -640.6% | -737.7% | -36.2% | -21.8% | 0.40 | 3.01 | -2.3 |